γH2AX DNA Damage Detection Kit (Mouse mAb/Red): Precision DSB Detection for Genomic Instability Research

Executive Summary: The γH2AX DNA Damage Detection Kit (Mouse mAb/Red), manufactured by APExBIO, employs a mouse monoclonal antibody targeting γ-H2AX (phosphorylated H2AX at serine 139), a canonical biomarker of DNA double-strand breaks (DSBs) (product page). This kit enables high-resolution visualization of DSBs using a red fluorescent anti-mouse Cy5 secondary antibody and nuclear DAPI staining for multiplexed imaging. Quantitative detection of γ-H2AX foci supports robust assessment of DNA damage response (DDR), genotoxicity, and apoptosis in mouse, human, and rat cell/tissue samples (contextual review). It is validated in advanced radiotherapy paradigms, including FLASH-RT, and integrates seamlessly into translational and preclinical research workflows (Xu et al., 2026). The kit's standardized protocol and reagent quality ensure reproducibility across experiments.

Biological Rationale

DNA double-strand breaks (DSBs) represent one of the most lethal forms of genomic insult, leading to cell cycle arrest, apoptosis, or oncogenic transformation if unrepaired. The histone variant H2AX is phosphorylated at serine 139 (γ-H2AX) within minutes of DSB induction by kinases ATM and ATR, forming foci at break sites (product protocol). γ-H2AX immunofluorescence is a gold-standard marker for DSBs in research and clinical assays (Redefining DNA Damage Detection). This phosphorylation event is an early and quantifiable response to genotoxic stress, enabling precise mapping of DNA damage and repair kinetics (Kit’s role in genomic instability). γ-H2AX detection is critical in cancer research, radiobiology, and toxicology.

Mechanism of Action of γH2AX DNA Damage Detection Kit (Mouse mAb/Red)

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) (SKU: K2275) operates via a two-step immunofluorescence protocol. First, fixed and permeabilized cells or tissue sections are incubated with a mouse monoclonal antibody highly specific for γ-H2AX (phosphorylated at S139) (APExBIO). After washing and blocking, a Cy5-conjugated anti-mouse secondary antibody binds the primary, producing red fluorescence at γ-H2AX foci. Simultaneous DAPI staining labels all nuclei in blue, providing a counterstain for cell counting and localization. Imaging is performed using fluorescence microscopy or high-content screening systems. The method yields discrete nuclear foci proportional to DSB frequency, facilitating quantitative analysis of DNA damage (Translational Power of γH2AX Immunofluorescence).

Evidence & Benchmarks

• γ-H2AX foci formation is detectable within 5–30 minutes of DSB induction in mammalian cells, with signal intensity correlating with DSB number (Xu et al., 2026, source).
• Use of γH2AX immunofluorescence enables quantification of DNA damage after exposure to radiotherapy, genotoxic drugs, or oxidative stress (internal source).
• The K2275 kit demonstrates high specificity for γ-H2AX in both cultured cells and paraffin-embedded tissue, with minimal cross-reactivity (internal Q&A).
• Validated in advanced radiotherapy models (e.g., FLASH-RT), γH2AX detection tracks DNA repair kinetics and apoptosis in vivo (Xu et al., 2026, source).
• Reproducibility is supported by standardized reagents (fixation, blocking, antibodies) and clear nuclear foci quantification protocols (scenario-driven guidance).

Applications, Limits & Misconceptions

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) is optimized for research applications including:

• Detection and quantification of DNA double-strand breaks (DSBs) in mammalian cells and tissues.
• Assessment of genotoxicity for drug candidates, chemicals, or irradiation protocols.
• Analysis of DNA repair pathway efficiency in genetic, pharmacological, or radiobiological studies.
• Evaluation of apoptosis following DNA damage induction.
• Translational and preclinical research in oncology, especially for radiotherapy optimization (e.g., FLASH-RT).

This article extends previous internal reviews by providing an updated, stepwise benchmark and troubleshooting guide for high-content integration (see prior review).

Common Pitfalls or Misconceptions

• γ-H2AX foci indicate DNA DSBs but cannot specify the break origin (e.g., ionizing radiation vs. replication stress) without additional markers.
• The kit is not validated for live-cell imaging; fixation is required, which precludes dynamic monitoring in real time.
• Signal quantification may be confounded by cell cycle stage or chromatin structure; controls are essential.
• Non-specific binding can occur if blocking or washing steps are insufficiently optimized.
• Quantification is semi-quantitative; for absolute DSB counts, orthogonal assays (e.g., comet assay) may be required.

Workflow Integration & Parameters

For optimal results, cells or tissues are fixed with the provided solution (10–20 min, room temperature), permeabilized, and blocked at 4°C. Incubation with the primary γ-H2AX antibody (dilution per protocol) is followed by detection with Cy5-conjugated secondary antibody (protected from light). DAPI is applied for 5–10 minutes prior to mounting. Typical imaging parameters: excitation 640 nm (Cy5-red), 350 nm (DAPI-blue); emission collection windows per instrument specifications. The kit is compatible with high-content screening and standard fluorescence microscopes (full protocol). Storage at 4°C or -20°C is mandatory for reagent stability.

For scenario-driven troubleshooting and optimization, see the practical Q&A guide (Solving DNA Damage Assay Challenges), which this article updates with new evidence from radiotherapy models.

Conclusion & Outlook

The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO provides a highly specific and reproducible solution for detecting DNA double-strand breaks in mammalian systems. Its integration into translational and preclinical research supports precision oncology, genotoxicity assessment, and apoptosis studies. The kit's validated performance in advanced paradigms such as FLASH-RT and its compatibility with high-content workflows make it a reference standard in DNA damage and repair research. Future developments may address live-cell detection and multiplexed damage/repair pathway analysis. For further strategic integration and benchmarking, compare with scenario-based guidance (practical advice).